---
figid: PMC6320836__ijms-19-03773-g006
figlink: /pmc/articles/PMC6320836/figure/ijms-19-03773-f006/
number: F6
caption: Status of proteins that participate in the autophagy pathway in glioblastoma.
  A lower expression of autophagy-related proteins like ULK1/2, FIP200, Beclin-1,
  LC3, UVRAG, Bif-1, Atg4c, and Atg5 has been shown in glioblastoma with respect to
  lower-grade gliomas, which lead to the progression of astrocytic tumors by inhibiting
  cell death (both autophagic and apoptotic). Conversely, an increase in autophagy
  in astrocytic tumors under adverse conditions has been reported to induce tumor
  survival, progression, and therapeutic resistance through an accumulation of the
  protein p62, metabolic supply, and activation of transcription factors that regulate
  the positive expression of genes with an important role in the tumor process. Black
  arrows (↓) mean activation, red truncated arrow (⊥) means inhibition.
pmcid: PMC6320836
papertitle: Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma.
reftext: Cristina Trejo-Solís, et al. Int J Mol Sci. 2018 Dec;19(12):3773.
pmc_ranked_result_index: '100370'
pathway_score: 0.6427064
filename: ijms-19-03773-g006.jpg
figtitle: Status of proteins that participate in the autophagy pathway in glioblastoma
year: '2018'
organisms: Homo sapiens
ndex: 5498d409-df24-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6320836__ijms-19-03773-g006.html
  '@type': Dataset
  description: Status of proteins that participate in the autophagy pathway in glioblastoma.
    A lower expression of autophagy-related proteins like ULK1/2, FIP200, Beclin-1,
    LC3, UVRAG, Bif-1, Atg4c, and Atg5 has been shown in glioblastoma with respect
    to lower-grade gliomas, which lead to the progression of astrocytic tumors by
    inhibiting cell death (both autophagic and apoptotic). Conversely, an increase
    in autophagy in astrocytic tumors under adverse conditions has been reported to
    induce tumor survival, progression, and therapeutic resistance through an accumulation
    of the protein p62, metabolic supply, and activation of transcription factors
    that regulate the positive expression of genes with an important role in the tumor
    process. Black arrows (↓) mean activation, red truncated arrow (⊥) means inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB2
  - ATG5
  - EGFR
  - MAP1LC3A
  - JUND
  - REL
  - HIF1A
  - ATG4C
  - PDGFRB
  - PDGFRA
  - JUN
  - SH3GLB1
  - RB1CC1
  - FLT4
  - UVRAG
  - FOSL1
  - RELA
  - RELB
  - KDR
  - FOSL2
  - CTNNB1
  - SQSTM1
  - FOS
  - ULK2
  - ULK1
  - FLT1
  - FOSB
  - NFKB1
  - JUNB
  - HIF-1a
genes:
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: ATG4C,ATG5.
  symbol: ATG5
  source: hgnc_symbol
  hgnc_symbol: ATG5
  entrez: '9474'
- word: EGFR,PDGFR,VEGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: LC-3,
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: HIF-1a).
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: ATG4C,ATG5.
  symbol: ATG4C
  source: hgnc_symbol
  hgnc_symbol: ATG4C
  entrez: '84938'
- word: PDGFR,
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR,
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: FIP200,UVRAG,BIF1,
  symbol: Bif-1
  source: hgnc_alias_symbol
  hgnc_symbol: SH3GLB1
  entrez: '51100'
- word: FIP200,UVRAG,BIF1,
  symbol: FIP200
  source: hgnc_alias_symbol
  hgnc_symbol: RB1CC1
  entrez: '9821'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: FIP200,UVRAG,BIF1,
  symbol: UVRAG
  source: hgnc_symbol
  hgnc_symbol: UVRAG
  entrez: '7405'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: (NFKB,AP-1,B-catenin,
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: P62/SQSTM1
  symbol: SQSTM1
  source: hgnc_symbol
  hgnc_symbol: SQSTM1
  entrez: '8878'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: ULK1/2,
  symbol: ULK2
  source: hgnc_symbol
  hgnc_symbol: ULK2
  entrez: '9706'
- word: ULK1/2,
  symbol: ULK1
  source: hgnc_symbol
  hgnc_symbol: ULK1
  entrez: '8408'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: (NFKB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AP-1,
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
chemicals: []
diseases:
- word: HIF-1a
  source: MESH
  identifier: C536041
figid_alias: PMC6320836__F6
redirect_from: /figures/PMC6320836__F6
figtype: Figure
---
